Edition:
India

Zhejiang Hisun Pharmaceutical Co Ltd (600267.SS)

600267.SS on Shanghai Stock Exchange

10.14CNY
27 May 2019
Change (% chg)

¥0.38 (+3.89%)
Prev Close
¥9.76
Open
¥9.85
Day's High
¥10.23
Day's Low
¥9.79
Volume
12,173,311
Avg. Vol
14,683,135
52-wk High
¥17.53
52-wk Low
¥7.71

Latest Key Developments (Source: Significant Developments)

Zhejiang Hisun Pharmaceutical's Board Appoints Li Yan As President
Monday, 13 May 2019 

May 13 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>::SAYS IT BOARD APPOINTMENTS LI YAN AS PRESIDENT.  Full Article

Zhejiang Hisun Pharmaceutical Swings To Red In 2018 With Net Loss Of 492.5 Mln Yuan
Monday, 22 Apr 2019 

April 22 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>::SAYS 2018 NET LOSS AT 492.5 MILLION YUAN ($73.38 million) VERSUS NET PROFIT OF 13.6 MILLION YUAN.  Full Article

Zhejiang Hisun Pharmaceutical Says Board Elects Jiang Guoping As Chairman
Thursday, 29 Nov 2018 

Nov 29 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>::SAYS BOARD ELECTS JIANG GUOPING AS CHAIRMAN.  Full Article

Zhejiang Hisun Pharmaceutical Chairman Resigns Due To Age And Health Reasons
Thursday, 8 Nov 2018 

Nov 8 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>::SAYS ITS CHAIRMAN BAI HUA RESIGNS DUE TO AGE AND HEALTH REASONS.  Full Article

Zhejiang Hisun Pharmaceutical receives approval for drug clinical trial
Monday, 21 May 2018 

May 21(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it received approval for drug clinical trial for a kind of injection, from China Food and Drug Administration.  Full Article

Zhejiang Hisun Pharmaceutical and unit obtain high-tech enterprise recognition and to enjoy tax preference
Thursday, 4 Jan 2018 

Jan 4(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it and unit were recognized as high-tech enterprise, and to enjoy a tax preference of 15 percent for three years .  Full Article

Zhejiang Hisun Pharmaceutical passes FDA approval
Tuesday, 21 Nov 2017 

Nov 21(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it received approval for a kind of tablet from U.S Food and Drug Administration .  Full Article

Zhejiang Hisun Pharmaceutical unit says product gets FDA approval
Monday, 20 Nov 2017 

Nov 20(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says co's Hangzhou-based unit's product simvastatin tablets, gets approval from U.S. Food and Drug Administration.  Full Article

Zhejiang Hisun Pharmaceutical says product gets FDA approval
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS> ::Says its product, mycophenolate mofetil capsules, gets approval from U.S. Food and Drug Administration .  Full Article

Zhejiang Hisun Pharmaceutical says change of CFO
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS> ::Says it appoints Liu Yuanyan as new CFO, replacing Guan Xuhua who resigns from the position due to internal change in job role.  Full Article